Rethinking the Use of Antidepressants to Treat Alcohol Use Disorders and Depression Comorbidity: The Role of Neurogenesis

  1. Gómez de Heras, Raquel 1
  2. Alén, Francisco 1
  3. Rodríguez de Fonseca, Fernando 1
  4. Orio, Laura 1
  5. Ballesta, Antonio 1
  1. 1 Universidad Complutense de Madrid
    info

    Universidad Complutense de Madrid

    Madrid, España

    ROR 02p0gd045

Libro:
Antidepressants - Preclinical, Clinical and Translational Aspects

Año de publicación: 2019

Tipo: Capítulo de Libro

DOI: 10.5772/INTECHOPEN.83743 GOOGLE SCHOLAR lock_openAcceso abierto editor

Objetivos de desarrollo sostenible

Resumen

Patients with alcohol use disorders (AUDs) are frequently treated with antidepressant drugs (ADs), but clinical evidence of their efficacy is contradictory. Considering that ADs are thought to produce their therapeutic effects partially by increasing hippocampal plasticity and neurogenesis (HN), and that both AUDs and depression share a potential for the disruption of these neuroplastic processes, one could reasonably wonder whether the poor efficacy of AD treatment could be explained by the inability of these drugs to exert their proper action in patients suffering from AUD or depression. In order to further clarify this question, this chapter aims to examine available data regarding the effect of ADs on behavioral and HN alterations related to alcohol abstinence, as a key period in which the treatment would be implemented and in which their potential effects on alcohol-related problems remain under controversy.

Referencias bibliográficas

  • 1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Vol. 5. Washington, DC: American Psychiatric Association; 2013
  • 2. Sullivan LE, Fiellin DA, O’Connor PG. The prevalence and impact of alcohol problems in major depression: A systematic review. The American Journal of Medicine. 2005;118(4):330-341. DOI: 10.1016/j.amjmed.2005.01.007
  • 3. Balu DT, Lucki I. Adult hippocampal neurogenesis: Regulation, functional implications, and contribution to disease pathology. Neuroscience and Biobehavioral Reviews. 2008;33(3):232-252. DOI: 10.1016/j.neubiorev.2008.08.007
  • 4. Baptista P, Andrade JP. Adult hippocampal neurogenesis: Regulation and possible functional and clinical correlates. Frontiers in Neuroanatomy. 2018;12:44. DOI: 10.3389/fnana.2018.00044
  • 5. Sahay A, Hen R. Adult hippocampal neurogenesis in depression. Nat Neurosci. 2007 Sep;10(9):1110-1115. DOI: 10.1038/nn1969
  • 6. Olsufka RA, Peng H, Newton JS, Nixon K. Alcohol effects on adult neural stem cells–A novel mechanism of neurotoxicity and recovery in alcohol use disorders. In: Rasmussen TP, editor. Stem Cells in Birth Defects Research and Developmental Toxicology. Hoboken, NJ: Wiley; 2018. DOI: 10.1002/9781119283249.ch8
  • 7. Jacobs BL, van Praag H, Gage FH. Adult brain neurogenesis and psychiatry: A novel theory of depression. Molecular Psychiatry. 2000;5:262-269
  • 8. Tanti A, Belzung C. Hippocampal neurogenesis: A biomarker for depression or antidepressant effects? Methodological considerations and perspectives for future research. Cell and Tissue Research. 2013;354(1):203-219. DOI: 10.1007/s00441-013-1612-z
  • 9. Peng L, Bonaguidi MA. Function and dysfunction of adult hippocampal neurogenesis in regeneration and disease. The American Journal of Pathology. 2018 Jan;188(1):23-28. DOI: 10.1016/j.ajpath.2017.09.004
  • 10. Renoir T, Pang TY, Lanfumey L. Drug withdrawal-induced depression: Serotonergic and plasticity changes in animal models. Neuroscience & Biobehavioral Reviews. 2012;36(1):696-726. DOI: 10.1016/j.neubiorev.2011.10.003
  • 11. Crews FT, Nixon K. Mechanisms of neurodegeneration and regeneration in alcoholism. Alcohol and Alcoholism. 2009;44(2):115-127. DOI: 10.1093/alcalc/agn079
  • 12. Chambers RA. Adult hippocampal neurogenesis in the pathogenesis of addiction and dual diagnosis disorders. Drug and Alcohol Dependence. 2013;130(1-3):1-12. DOI: 10.1016/j.drugalcdep.2012.12.005
  • 13. Mandyam CD, Koob GF. The addicted brain craves new neurons: Putative role for adult-born progenitors in promoting recovery. Trends in Neurosciences. 2012;35(4):250-260. DOI: 10.1016/j.tins.2011.12.005
  • 14. Abbing-Karahagopian V, Huerta C, Souverein PC, de Abajo F, Leufkens HGM, Slattery J, et al. Antidepressant prescribing in five European countries: Application of common definitions to assess the prevalence, clinical observations, and methodological implications. European Journal of Clinical Pharmacology. 2014;70(7):849-857. DOI: 10.1007/s00228-014-1676-z
  • 15. Marcinkiewcz CA, Lowery-Gionta EG, Kash TL. Serotonin's complex role in alcoholism: Implications for treatment and future research. Alcoholism, Clinical and Experimental Research. 2016 Jun;40(6):1192-1201. DOI: 10.1111/acer.13076
  • 16. Soyka M, Müller CA. Pharmacotherapy of alcoholism—An update on approved and off-label medications. Expert Opinion on Pharmacotherapy. 2017;18(12):1187-1199. DOI: 10.1080/14656566.2017.1349098
  • 17. Schildkraut JJ. The catecholamine hypothesis of affective disorders: A review of supporting evidence. The Journal of Neuropsychiatry and Clinical Neurosciences. 1995 Fall;7(4):524-533; discussion 523-4
  • 18. Duman RS, Nakagawa S, Malberg J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology. 2001;25(6):836-844
  • 19. Mahar I, Bambico FR, Mechawar N, Nobrega JN. Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects. Neuroscience and Biobehavioral Reviews. 2014;38:173-192. DOI: 10.1016/j.neubiorev.2013.11.009
  • 20. Boldrini M, Underwood MD, Hen R, Rosoklija GB, Dwork AJ, Mann JJ, et al. Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology. 2009;34(11):2376-2389. DOI: 10.1038/npp.2009.75
  • 21. Boldrini M, Hen R, Underwood MD, Rosoklija GB, Dwork AJ, Mann JJ, et al. Hippocampal angiogenesis and progenitor cell proliferation are increased with antidepressant use in major depression. Biological Psychiatry. 2012;72(7):562-571. DOI: 10.1016/j.biopsych.2012.04.024
  • 22. Boldrini M, Butt TH, Santiago AN, Tamir H, Dwork AJ, Rosoklija GB, et al. Benzodiazepines and the potential trophic effect of antidepressants on dentate gyrus cells in mood disorders. The International Journal of Neuropsychopharmacology. 2014;17(12):1923-1933. DOI: 10.1017/s1461145714000844
  • 23. Boldrini M, Santiago AN, Hen R, Dwork AJ, Rosoklija GB, Tamir H, et al. Hippocampal granule neuron number and dentate gyrus volume in antidepressant-treated and untreated major depression. Neuropsychopharmacology. 2013 May;38(6):1068-1077. DOI: 10.1038/npp.2013.5
  • 24. Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. The Journal of Neuroscience. 2000;20(24):9104-9110
  • 25. Kempermann G, Gage FH, Aigner L, Song H, Curtis MA, Thuret S, et al. Human adult neurogenesis: Evidence and remaining questions. Cell Stem Cell. 2018;23(1):25-30. DOI: 10.1016/j.stem.2018.04.004
  • 26. Eliwa H, Belzung C, Surget A. Adult hippocampal neurogenesis: Is it the alpha and omega of antidepressant action? Biochemical Pharmacology. 2017;141:86-99. DOI: 10.1016/j.bcp.2017.08.005
  • 27. Hershon HI. Alcohol withdrawal symptoms and drinking behavior. Journal of Studies on Alcohol. 1977;38(5):953-971
  • 28. Koob GF. The dark side of emotion: The addiction perspective. European Journal of Pharmacology. 2015;753:73-87. DOI: 10.1016/j.ejphar.2014.11.044
  • 29. Conner KR, Pinquart M, Gamble SA. Meta-analysis of depression and substance use among individuals with alcohol use disorders. Journal of Substance Abuse Treatment. 2009;37(2):127-137. DOI: 10.1016/j.jsat.2008.11.007
  • 30. Brennan PL, SooHoo S, Lemke S, Schutte KK. Alcohol use predicts 10-year depressive symptom trajectories in the health and retirement study. Journal of Aging and Health. 2016;28(5):911-932. DOI: 10.1177/0898264315615837
  • 31. Skogen JC, Knudsen AK, Hysing M, Wold B, Sivertsen B. Trajectories of alcohol use and association with symptoms of depression from early to late adolescence: The Norwegian Longitudinal Health Behaviour Study. Drug and Alcohol Review. 2016;35(3):307-316. DOI: 10.1111/dar.12350
  • 32. Foulds JA, Adamson SJ, Boden JM, Williman JA, Mulder RT. Depression in patients with alcohol use disorders: Systematic review and meta-analysis of outcomes for independent and substance-induced disorders. Journal of Affective Disorders. 2015;185:47-59. DOI: 10.1016/j.jad.2015.06.024
  • 33. Brown RA, Ramsey SE, Kahler CW, Palm KM, Monti PM, Abrams D, et al. A randomized controlled trial of cognitive-behavioral treatment for depression versus relaxation training for alcohol-dependent individuals with elevated depressive symptoms. Journal of Studies on Alcohol and Drugs. 2011;72:286. DOI: 10.15288/jsad.2011.72.286
  • 34. Foulds JA, Douglas Sellman J, Adamson SJ, Boden JM, Mulder RT, Joyce PR. Depression outcome in alcohol dependent patients: An evaluation of the role of independentand substance-induced depression and other predictors. Journal of Affective Disorders. 2015;174:503-510. DOI: 10.1016/j.jad.2014.11.052
  • 35. Bahorik AL, Leibowitz A, Sterling SA, Travis A, Weisner C, Satre DD. The role of hazardous drinking reductions in predicting depression and anxiety symptom improvement among psychiatry patients: A longitudinal study. Journal of Affective Disorders. 2016;206:169-173. DOI: 10.1016/j.jad.2016.07.039
  • 36. Getachew B, Hauser SR, Taylor RE, Tizabi Y. Desipramine blocks alcohol-induced anxiety- and depressive-like behaviors in two rat strains. Pharmacology, Biochemistry, and Behavior. 2008;91:97-103. DOI: 10.1016/j.pbb.2008.06.016
  • 37. Stevenson JR, Schroeder JP, Nixon K, Besheer J, Crews FT, Hodge CW. Abstinence following alcohol drinking produces depression-like behavior and reduced hippocampal neurogenesis in mice. Neuropsychopharmacology. 2009;34:1209-1222. DOI: 10.1038/npp.2008.90
  • 38. Ehlers CL, Liu W, Wills DN, Crews FT. Periadolescent ethanol vapor exposure persistently reduces measures of hippocampal neurogenesis that are associated with behavioral outcomes in adulthood. Neuroscience. 2013;244:1-15. DOI: 10.1016/j.neuroscience.2013.03.058
  • 39. Warnock KT, Yang ARST, Yi HS, June HL, Kelly T, Basile AS, et al. Amitifadine, a triple monoamine uptake inhibitor, reduces binge drinking and negative affect in an animal model of co-occurring alcoholism and depression symptomatology. Pharmacology Biochemistry and Behavior. 2012;103(1):111-118. DOI: 10.1016/j.pbb.2012.07.014
  • 40. Briones TL, Woods J. Chronic binge-like alcohol consumption in adolescence causes depression-like symptoms possibly mediated by the effects of BDNF on neurogenesis. Neuroscience. 2013;254:324-334. DOI: 10.1016/j.neuroscience.2013.09.031
  • 41. Pang TY, Renoir T, Du X, Lawrence AJ, Hannan AJ. Depression-related behaviours displayed by female C57BL/6J mice during abstinence from chronic ethanol consumption are rescued by wheel-running. The European Journal of Neuroscience. 2013;37(11):1803-1810. DOI: 10.1111/ejn.12195
  • 42. Holleran KM, Wilson HH, Fetterly TL, et al. Ketamine and MAG lipase inhibitor-dependent reversal of evolving depressive-like behavior during forced abstinence from alcohol drinking. Neuropsychopharmacology. 2016;41(8):2062-2071. DOI: 10.1038/npp.2016.3
  • 43. Getachew B, Hauser SR, Csoka AB11, Taylor RE, Tizabi Y. Role of cortical alpha-2 adrenoceptors in alcohol withdrawal-induced depression and tricyclic antidepressants. Drug and Alcohol Dependence. 2017;175:133-139. DOI: 10.1016/j.drugalcdep.2017.03.004
  • 44. Kim HJ, Park SD, Lee RM, Lee BH, Choi SH, Hwang SH, et al. Gintonin attenuates depressive-like behaviors associated with alcohol withdrawal in mice. Journal of Affective Disorders. 2017;215:23-29. DOI: 10.1016/j.jad.2017.03.026
  • 45. Gong MF, Wen RT, Xu Y, Pan JC, Fei N, Zhou YM, et al. Attenuation of ethanol abstinence-induced anxiety- and depressive-like behavior by the phosphodiesterase-4 inhibitor rolipram in rodents. Psychopharmacology. 2017;234(20):3143-3151. DOI: 10.1007/s00213-017-4697-3
  • 46. Vranjkovic O, Winkler G, Winder DG. Ketamine administration during a critical period after forced ethanol abstinence inhibits the development of time-dependent affective disturbances. Neuropsychopharmacology. 2018 Aug;43(9):1915-1923. DOI: 10.1038/s41386-018-0102-0
  • 47. Lee KM, Coehlo MA, Solton NR, Szumlinski KK. Negative affect and excessive alcohol intake incubate during protracted withdrawal from binge-drinking in adolescent, but not adult mice. Frontiers in Psychology. 2017;8:1128. DOI: 10.3389/fpsyg.2017.01128
  • 48. Markou A, Kosten TR, Koob GF. Neurobiological similarities in depression and drug dependence: A self-medication hypothesis. Neuropsychopharmacology. 1998;18(3):135-174
  • 49. Durazzo TC, Meyerhoff DJ. Psychiatric, demographic, and brain morphological predictors of relapse after treatment for an alcohol use disorder. Alcoholism, Clinical and Experimental Research. 2016;41(1):107. DOI: 116. 10.1111/acer.13267
  • 50. Milton AL, Everitt BJ. The psychological and neurochemical mechanisms of drug memory reconsolidation: Implications for the treatment of addiction. The European Journal of Neuroscience. 2010;31(12):2308-2319. DOI: 10.1111/j.1460-9568.2010.07249.x
  • 51. Strowig AB. Relapse determinants reported by men treated for alcohol addiction: The prominence of depressed mood. Journal of Substance Abuse Treatment. 2000 Dec;19(4):469-474
  • 52. Cengisiz C, Deveci A, Yapici A. Effects of depression on treatment motivation in male alcohol dependence. Noro Psikiyatri Arsivi. 2015;52(4):412-416. DOI: 10.5152/npa.2015.9859
  • 53. Holzhauer CG, Gamble SA. Depressive symptoms mediate the relationship between changes in emotion regulation during treatment and abstinence among women with alcohol use disorders. Psychology of Addictive Behaviors. 2017;31(3):284-294. DOI: 10.1037/adb0000274
  • 54. Suter M, Strik W, Moggi F. Depressive symptoms as a predictor of alcohol relapse after residential treatment programs for alcohol use disorder. Journal of Substance Abuse Treatment. 2011;41(3):225-232. DOI: 10.1016/j.jsat.2011.03.005
  • 55. Heilig M, Egli M, Crabbe JC, Becker HC. Acute withdrawal, protracted abstinence and negative affect in alcoholism: Are they linked? Addiction Biology. 2010;15(2):169-184. DOI: 10.1111/j.1369-1600.2009.00194.x
  • 56. Samet S, Fenton MC, Nunes E, Greenstein E, Aharonovich E, Hasin D. Effects of independent and substance-induced major depressive disorder on remission and relapse of alcohol, cocaine and heroin dependence. Addiction. 2012;108(1):115-123. DOI: 10.1111/j.1360-0443.2012.04010.x
  • 57. Ng E, Browne CJ, Samsom JN, AHC W. Depression and substance use comorbidity: What we have learned from animal studies. The American Journal of Drug and Alcohol Abuse. 2017;43(4):456-474. DOI: 10.1080/00952990.2016.1183020
  • 58. Riga D, Schmitz LJ, van der Harst JE, van Mourik Y, Hoogendijk WJ, Smit AB, et al. A sustained depressive state promotes a guanfacine reversible susceptibility to alcohol seeking in rats. Neuropsychopharmacology. 2014;39(5):1115-1124. DOI: 10.1038/npp.2013.311
  • 59. Le Maître TW, Dhanabalan G, Bogdanovic N, Alkass K, Druid H. Effects of alcohol abuse on proliferating cells, stem/progenitor cells, and immature neurons in the adult human hippocampus. Neuropsychopharmacology. 2018;43(4):690-699. DOI: 10.1038/npp.2017.251
  • 60. Bayer R, Franke H, Ficker C, Richter M, Lessig R, Büttner A, et al. Alterations of neuronal precursor cells in stages of human adult neurogenesis in heroin addicts. Drug and Alcohol Dependence. 2015;156:139-149. DOI: 10.1016/j.drugalcdep.2015.09.005
  • 61. Wilson S, Bair JL, Thomas KM, Iacono WG. Problematic alcohol use and reduced hippocampal volume: A meta-analytic review. Psychological Medicine. 2017;47(13):2288-2301. DOI: 10.1017/S0033291717000721
  • 62. Staples MC, Mandyam CD. Thinking after drinking: Impaired hippocampal-dependent cognition in human alcoholics and animal models of alcohol dependence. Frontiers in Psychiatry. 2016;7:162. DOI: 10.3389/fpsyt.2016.00162
  • 63. Xu C, Loh HH, Law PY. Effects of addictive drugs on adult neural stem/progenitor cells. Cellular and Molecular Life Sciences. 2015;73(2):327-348. DOI: 10.1007/s00018-015-2067-z
  • 64. Nixon K, Kim DH, Potts EN, He J, Crews FT. Distinct cell proliferation events during abstinence after alcohol dependence: Microglia proliferation precedes neurogenesis. Neurobiology of Disease. 2008;31(2):218-229. DOI: 10.1016/j.nbd.2008.04.009
  • 65. Maynard ME, Leasure JL. Exercise enhances hippocampal recovery following binge ethanol exposure. PLoS ONE. 2013;8(9):e76644. DOI: 10.1371/journal.pone.0076644
  • 66. McClain JA, Morris SA, Marshall SA, Nixon K. Ectopic hippocampal neurogenesis in adolescent male rats following alcohol dependence. Addiction Biology. 2013;19(4):687-699. DOI: 10.1111/adb.12075
  • 67. Nickell CRG, Peng H, Hayes DM, Chen KY, McClain JA, Nixon K. Type 2 neural progenitor cell activation drives reactive neurogenesis after binge-like alcohol exposure in adolescent male rats. Frontiers in Psychiatry. 2017;8:283. DOI: 10.3389/fpsyt.2017.00283
  • 68. Hayes DM, Nickell CG, Chen KY, McClain JA, Heath MM, Deeny MA, et al. Activation of neural stem cells from quiescence drives reactive hippocampal neurogenesis after alcohol dependence. Neuropharmacology. 2018;133:276-288. DOI: 10.1016/j.neuropharm.2018.01.032
  • 69. Hansson AC, Nixon K, Rimondini R, et al. Long-term suppression of forebrain neurogenesis and loss of neuronal progenitor cells following prolonged alcohol dependence in rats. The International Journal of Neuropsychopharmacology. 2010;13(5):583-593. DOI: 10.1017/S1461145710000246
  • 70. Crews FT, Mdzinarishvili A, Kim D, He J, Nixon K. Neurogenesis in adolescent brain is potently inhibited by ethanol. Neuroscience. 2006;137(2):437-445. DOI: 10.1016/j.neuroscience.2005.08.090
  • 71. Richardson HN, Chan SH, Crawford EF, Lee YK, Funk CK, Koob GF, et al. Permanent impairment of birth and survival of cortical and hippocampal proliferating cells following excessive drinking during alcohol dependence. Neurobiology of Disease. 2009;36(1):1-10. DOI: 10.1016/j.nbd.2009.05.021
  • 72. Taffe MA, Kotzebue RW, Crean RD, Crawford EF, Edwards S, Mandyam CD. Long-lasting reduction in hippocampal neurogenesis by alcohol consumption in adolescent nonhuman primates. Proceedings of the National Academy of Sciences. 2010;107(24):11104-11109. DOI: 10.1073/pnas.0912810107
  • 73. Broadwater MA, Liu W, Crews FT, Spear LP. Persistent loss of hippocampal neurogenesis and increased cell death following adolescent, but not adult chronic ethanol exposure. Developmental Neuroscience. 2014;36(3-4):297-305. DOI: 10.1159/000362874
  • 74. Vetreno RP, Crews FT. Binge ethanol exposure during adolescence leads to a persistent loss of neurogenesis in the dorsal and ventral hippocampus that is associated with impaired adult cognitive functioning. Frontiers in Neuroscience. 2015;9:35. DOI: 10.3389/fnins.2015.00035
  • 75. Morris SA, Eaves DW, Smith AR, Nixon K. Alcohol inhibition of neurogenesis: A mechanism of hippocampal neurodegeneration in an adolescent alcohol abuse model. Hippocampus. 2010;20(5):596-607. DOI: 10.1002/hipo.20665
  • 76. Sakharkar AJ, Vetreno RP, Zhang H, Kokare DM, Crews FT, Pandey SC. A role for histone acetylation mechanisms in adolescent alcohol exposure-induced deficits in hippocampal brain-derived neurotrophic factor expression and neurogenesis markers in adulthood. Brain Structure and Function. 2016;221(9):4691-4703. DOI: 10.1007/s00429-016-1196-y
  • 77. Vetreno RP, Lawrimore CJ, Rowsey PJ, Crews FT. Persistent adult neuroimmune activation and loss of hippocampal neurogenesis following adolescent ethanol exposure: Blockade by exercise and the anti-inflammatory drug indomethacin. Frontiers in Neuroscience. 2018;12. DOI: 10.3389/fnins.2018.00200
  • 78. Somkuwar SS, Fannon MJ, Staples MC, Zamora-Martinez ER, Navarro AI, Kim A, et al. Alcohol dependence-induced regulation of the proliferation and survival of adult brain progenitors is associated with altered BDNF-TrkB signaling. Brain Structure & Function. 2016;221(9):4319-4335. DOI: 10.1007/s00429-015-1163-z
  • 79. Liu W, Crews FT. Persistent decreases in adult subventricular and hippocampal neurogenesis following adolescent intermittent ethanol exposure. Frontiers in Behavioral Neuroscience. 2017;11:151. DOI: 10.3389/fnbeh.2017.00151
  • 80. Kutlu MG, Gould TJ. Effects of drugs of abuse on hippocampal plasticity and hippocampus-dependent learning and memory: Contributions to development and maintenance of addiction. Learning & Memory. 2016;23(10):515-533. DOI: 10.1101/lm.042192.116
  • 81. Canales JJ. Deficient plasticity in the hippocampus and the spiral of addiction: Focus on adult neurogenesis. Current Topics in Behavioral Neurosciences. 2013;15:293-312. DOI: 10.1007/7854_2012_230
  • 82. Cui C, Noronha A, Warren K, Koob GF, Sinha R, Thakkar M, et al. Brain pathways to recovery from alcohol dependence. Alcohol (Fayetteville, N.Y.). 2015;49(5):435-452. DOI: 10.1016/j.alcohol.2015.04.006
  • 83. Kühn S, Charlet K, Schubert F, Kiefer F, Zimmermann P, Heinz A, et al. Plasticity of hippocampal subfield volume cornu ammonis 2+3 over the course of withdrawal in patients with alcohol dependence. JAMA Psychiatry. 2014;71(7):806-811. DOI: 10.1001/jamapsychiatry.2014.352
  • 84. Gross CM, Spiegelhalder K, Mercak J, Feige B, Langosch JM. Predictability of alcohol relapse by hippocampal volumetry and psychometric variables. Psychiatry Research. 2013;212(1):14-18. DOI: 10.1016/j.pscychresns.2012.09.011
  • 85. Danovitch I, Steiner AJ, Kazdan A, Goldenberg M, Haglund M, Mirocha J, et al. Analysis of patient-reported outcomes of quality of life and functioning before and after treatment of major depressive disorder comorbid with alcohol use disorders. Journal of Addiction Medicine. 2017;11(1):47-54. DOI: 10.1097/adm.0000000000000268
  • 86. Davis LL, Wisniewski SR, Howland RH, Trivedi MH, Husain MM, Fava M, et al. Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes. Drug and Alcohol Dependence. 2010;107(2-3):161-170. DOI: 10.1016/j.drugalcdep.2009.10.003
  • 87. Nunes EV, Levin FR. Treatment of depression in patients with alcohol or other drug dependence: A meta-analysis. JAMA. 2004;291(15):1887-1896. DOI: 10.1001/jama.291.15.1887
  • 88. Iovieno N, Tedeschini E, Bentley KH, Evins AE, Papakostas GI. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: A meta-analysis of placebo-controlled randomized trials. The Journal of Clinical Psychiatry. 2011;72(8):1144-1151. DOI: 10.4088/JCP.10m06217
  • 89. Zhou X, Qin B, Del Giovane C, Pan J, Gentile S, Liu Y, et al. Efficacy and tolerability of antidepressants in the treatment of adolescents and young adults with depression and substance use disorders: A systematic review and meta-analysis. Addiction. 2015;110(1):38-48. DOI: 10.1111/add.12698.10
  • 90. Torrens M, Fonseca F, Mateu G, Farré M. Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis. Drug and Alcohol Dependence. 2005;78(1):1-22. DOI: 10.1016/j.drugalcdep.2004.09.004
  • 91. Cornelius J, Chung T, Douaihy A, Kirisci L, Glance J, Kmiec J, et al. A review of the literature of mirtazapine in co-occurring depression and an alcohol use disorder. Journal of Addictive Behaviors, Therapy & Rehabilitation. 2016;5(4):159. DOI: 10.4172/2324-9005.1000159
  • 92. Agabio R, Trogu E, Pani PP. Antidepressants for the treatment of people with co-occurring depression and alcohol dependence. Cochrane Database of Systematic Reviews. 2018;4. Art. No.: CD008581. DOI: 10.1002/14651858.CD008581.pub2
  • 93. Nunes EV, Levin FR. Treatment of co-occurring depression and substance dependence: Using meta-analysis to guide clinical recommendations. Psychiatric Annals. 2008;38(11)
  • 94. Belmer A, Patkar OL, Pitman KM, Bartlett SE. Serotonergic neuroplasticity in alcohol addiction. Brain Plasticity. 2016;1(2):177-206. DOI: 10.3233/BPL-150022
  • 95. Hill AS, Sahay A, Hen R. Increasing adult hippocampal neurogenesis is sufficient to reduce anxiety and depression-like behaviors. Neuropsychopharmacology. 2015;40(10):2368-2378. DOI: 10.1038/npp.2015.85
  • 96. Bessa JM, Ferreira D, Melo I, Marques F, Cerqueira JJ, Palha JA, et al. The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Molecular Psychiatry. 2009;14(8):764-773. DOI: 10.1038/mp.2008.119
  • 97. Mateus-Pinheiro A, Pinto L, Bessa JM, Morais M, Alves ND, Monteiro S, et al. Sustained remission from depressive-like behavior depends on hippocampal neurogenesis. Translational Psychiatry. 2013;3(1):e210. DOI: 10.1038/tp.2012.141
  • 98. Graham K, Massak A. Alcohol consumption and the use of antidepressants. CMAJ. 2007;176(5):633-637. DOI: 10.1503/cmaj.060446
  • 99. Mann K. Pharmacotherapy of alcohol dependence: A review of the clinical data. CNS Drugs. 2004;18(8):485-504. DOI: 10.2165/00023210-200418080-00002
  • 100. Charney DA, Heath LM, Zikos E, Palacios-Boix J, Gill KJ. Poorer drinking outcomes with citalopram treatment for alcohol dependence: A randomized, double-blind, placebo-controlled trial. Alcoholism, Clinical and Experimental Research. 2015;39(9):1756-1765. DOI: 10.1111/acer.12802
  • 101. Chick J, Aschauer H, Hornik K. Efficacy of fluvoxamine in preventing relapse in alcohol dependence: A one-year, double-blind, placebo-controlled multicentre study with analysis by typology. Drug and Alcohol Dependence. 2004;74(1):61-70. DOI: 10.1016/j.drugalcdep.2003.11.012
  • 102. Dundon W, Lynch KG, Pettinati HM, Lipkin C. Treatment outcomes in type A and B alcohol dependence 6 months after serotonergic pharmacotherapy. Alcoholism: Clinical and Experimental Research. 2004;28:1065-1073. DOI: 10.1097/01.alc.0000130974.50563.04
  • 103. Atigari OV, Kelly AM, Jabeen Q, Healy D. New onset alcohol dependence linked to treatment with selective serotonin reuptake inhibitors. The International Journal of Risk & Safety in Medicine. 2013;25(105-109). DOI: 10.3233/JRS-130586
  • 104. Brookwell L, Hogana C, Healya D, Manginb D. Ninety-three cases of alcohol dependence following SSRI treatment. The International Journal of Risk & Safety in Medicine. 2014;26:99-107. DOI: 10.3233/JRS-140616
  • 105. Menkes DB, Herxheimer A. Interaction between antidepressants and alcohol: Signal amplification by multiple case reports. The International Journal of Risk & Safety in Medicine. 2014;26(3):163-170. DOI: 10.3233/JRS-140632
  • 106. Gimeno C, Dorado ML, Roncero C, Szerman N, Vega P, Balanzá-Martínez V, et al. Treatment of comorbid alcohol dependence and anxiety disorder: Review of the scientific evidence and recommendations for treatment. Frontiers in Psychiatry. 2017;8:173. DOI: 10.3389/fpsyt.2017.00173
  • 107. Barajaz AM, Kliethermes CL. An assessment of the utilization of the preclinical rodent model literature in clinical trials of putative therapeutics for the treatment of alcohol use disorders. Drug and Alcohol Dependence. 2017;181:77-84. DOI: 10.1016/j.drugalcdep.2017.09.022
  • 108. Simon O’Brien E, Legastelois R, Houchi H, Vilpoux C, Alaux-Cantin S, Pierrefiche O, et al. Fluoxetine, desipramine, and the dual antidepressant milnacipran reduce alcohol self-administration and/or relapse in dependent rats. Neuropsychopharmacology. 2011;36:1518-1530. DOI: 10.1038/npp.2011.37
  • 109. Bell RL, Hauser SR, Liang T, Sari Y, Maldonado-Devincci A, Rodd ZA. Rat animal models for screening medications to treat alcohol use disorders. Neuropharmacology. 2017;122:201-243. DOI: 10.1016/j.neuropharm.2017.02.004
  • 110. Ho AMC, Qiu Y, Jia YF, Aguiar FS, Hinton DJ, Karpyak VM, et al. Combined effects of acamprosate and escitalopram on ethanol consumption in mice. Alcoholism, Clinical and Experimental Research. 2016;40(7):1531-1539. DOI: 10.1111/acer.13099
  • 111. Gulley JM, McNamara C, Barbera TJ, Ritz MC, George FR. Selective serotonin reuptake inhibitors: Effects of chronic treatment on ethanol-reinforced behavior in mice. Alcohol. 1995;12(3):177-181. DOI: 10.1016/0741-8329(94)00079-s
  • 112. Skelly MJ, Weiner JL. Chronic treatment with prazosin or duloxetine lessens concurrent anxiety-like behavior and alcohol intake: Evidence of disrupted noradrenergic signaling in anxiety-related alcohol use. Brain and Behavior. 2014;4(4):468-483. DOI: 10.1002/brb3.230
  • 113. Alén F, Orio L, Gorriti MA, de Heras RG, Ramírez-López MT, Pozo MA, et al. Increased alcohol consumption in rats after subchronic antidepressant treatment. The International Journal of Neuropsychopharmacology. 2013;16:1809-1818. DOI: 10.1017/s1461145713000217
  • 114. Alén F, Serrano A, Gorriti MÁ, Pavón FJ, Orio L, de Heras RG, et al. The administration of atomoxetine during alcohol deprivation induces a time-limited increase in alcohol consumption after relapse. The International Journal of Neuropsychopharmacology. 2014;17(11):1905-1910. DOI: 10.1017/s146114571400087x